Phase II Clinical Trial of CPI 613 in Patients With Locally Advanced or Metastatic Pancreatic Cancer

Trial Profile

Phase II Clinical Trial of CPI 613 in Patients With Locally Advanced or Metastatic Pancreatic Cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 12 Nov 2013

At a glance

  • Drugs CPI 613 (Primary)
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Sponsors Rafael Pharmaceuticals
  • Most Recent Events

    • 12 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top